• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.

    4/18/25 5:24:02 PM ET
    $SIBN
    Medical/Dental Instruments
    Health Care
    Get the next $SIBN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 4)


    SI-BONE, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    825704109

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    825704109


    1Names of Reporting Persons

    BROWN ADVISORY INC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,669,868.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    3,219,079.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    3,219,079.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.6 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    825704109


    1Names of Reporting Persons

    BROWN INVESTMENT ADVISORY & TRUST CO
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    18,203.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    18,203.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    18,203.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    BK


    SCHEDULE 13G

    CUSIP No.
    825704109


    1Names of Reporting Persons

    BROWN ADVISORY LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,650,771.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    3,198,548.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    3,198,548.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.5 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    825704109


    1Names of Reporting Persons

    SIGNATURE FINANCIAL MANAGEMENT, INC.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    VIRGINIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    894.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    2,328.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,328.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    SI-BONE, Inc.
    (b)Address of issuer's principal executive offices:

    471 El Camino Real Suite 101 Santa Clara, CALIFORNIA 95050
    Item 2. 
    (a)Name of person filing:

    BROWN ADVISORY INC BROWN INVESTMENT ADVISORY & TRUST CO BROWN ADVISORY LLC SIGNATURE FINANCIAL MANAGEMENT, INC.
    (b)Address or principal business office or, if none, residence:

    901 SOUTH BOND STREET SUITE #400 Baltimore, Maryland 21231
    (c)Citizenship:

    BROWN ADVISORY INC - MARYLAND BROWN INVESTMENT ADVISORY & TRUST CO - MARYLAND BROWN ADVISORY LLC - MARYLAND SIGNATURE FINANCIAL MANAGEMENT, INC. - VIRGINIA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    825704109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    3,219,079
    (b)Percent of class:

    7.6  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    BROWN ADVISORY INC - 2,669,868 BROWN INVESTMENT ADVISORY & TRUST CO - 18,203 BROWN ADVISORY LLC - 2,650,771 SIGNATURE FINANCIAL MANAGEMENT, INC. - 894

     (ii) Shared power to vote or to direct the vote:

    BROWN ADVISORY INC - 0 BROWN INVESTMENT ADVISORY & TRUST CO - 0 BROWN ADVISORY LLC - 0 SIGNATURE FINANCIAL MANAGEMENT, INC. - 0

     (iii) Sole power to dispose or to direct the disposition of:

    BROWN ADVISORY INC - 0 BROWN INVESTMENT ADVISORY & TRUST CO - 0 BROWN ADVISORY LLC - 0 SIGNATURE FINANCIAL MANAGEMENT, INC. - 0

     (iv) Shared power to dispose or to direct the disposition of:

    BROWN ADVISORY INC - 3,219,079 BROWN INVESTMENT ADVISORY & TRUST CO - 18,203 BROWN ADVISORY LLC - 3,198,548 SIGNATURE FINANCIAL MANAGEMENT, INC. - 2,328

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The total securities being reported are beneficially owned by investment companies and other managed accounts of direct/indirect subsidiaries of BROWN ADVISORY INC (listed above). These subsidiaries may be deemed to be beneficial owners of the reported securities because applicable investment advisory contracts provide voting and/or investment power over securities.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    BROWN ADVISORY INC is a parent holding company filing this schedule on behalf of the following subsidiaries pursuant to Rule 13d-1(b)(1)(ii)(G) under the Securities Exchange Act of 1934: BROWN INVESTMENT ADVISORY & TRUST CO - BK (Bank) BROWN ADVISORY LLC - IA (Investment Adviser) SIGNATURE FINANCIAL MANAGEMENT, INC. - IA (Investment Adviser)
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    BROWN ADVISORY INC
     
    Signature:Brett D. Rogers
    Name/Title:General Counsel & Chief Compliance Officer
    Date:04/18/2025
     
    BROWN INVESTMENT ADVISORY & TRUST CO
     
    Signature:Brett D. Rogers
    Name/Title:General Counsel & Chief Compliance Officer
    Date:04/18/2025
     
    BROWN ADVISORY LLC
     
    Signature:Brett D. Rogers
    Name/Title:General Counsel & Chief Compliance Officer
    Date:04/18/2025
     
    SIGNATURE FINANCIAL MANAGEMENT, INC.
     
    Signature:Brett D. Rogers
    Name/Title:General Counsel & Chief Compliance Officer
    Date:04/18/2025
    Get the next $SIBN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SIBN

    DatePrice TargetRatingAnalyst
    8/6/2024$27.00 → $19.00Buy
    Needham
    3/28/2024$25.00Overweight
    Piper Sandler
    10/12/2022$20.00Buy
    Jefferies
    4/7/2022$34.00Overweight
    Cantor Fitzgerald
    3/1/2022$30.00 → $28.00Overweight
    Morgan Stanley
    1/18/2022$43.00 → $36.00Buy
    B of A Securities
    12/21/2021$35.00 → $30.00Buy
    Truist Securities
    11/9/2021$42.00 → $36.00Market Outperform
    JMP Securities
    More analyst ratings

    $SIBN
    Financials

    Live finance-specific insights

    See more
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Francis Laura sold $661,368 worth of shares (38,504 units at $17.18) (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:01:42 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Maheshwari Anshul sold $599,033 worth of shares (33,287 units at $18.00), decreasing direct ownership by 12% to 237,006 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:00:36 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Director Dunn Jeffrey W sold $4,628 worth of shares (336 units at $13.78), decreasing direct ownership by 3% to 12,536 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/2/25 5:08:52 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by SI-BONE Inc.

      SC 13G/A - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 6:27:27 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 4:43:38 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/8/24 12:14:44 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Leadership Updates

    Live Leadership Updates

    See more
    • Bruker Appoints Laura Francis to its Board of Directors

      Bruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (NASDAQ:SIBN), a medical device company solving musculoskeletal disorders of the sacropelvic anatomy. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Prior to joining SI-BONE, Ms. Francis held other executive and leadership roles with

      2/21/25 8:00:00 AM ET
      $BRKR
      $PGNY
      $SIBN
      $SWAV
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Misc Health and Biotechnology Services
      Health Care
    • Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

      Mainstay Medical Holdings plc today announced the appointment of two new independent members to the company's board of directors, Jeffrey Dunn and Eric Major. These appointments bring Mainstay's total board membership to seven. "We are pleased to welcome these two transformational business leaders as new independent directors on the Board," said David Brabazon, Chairman of the Mainstay Board of Directors. "Their deep experience will be invaluable to Mainstay as we grow our business and pursue our mission to serve patients with intractable chronic low back pain." "As our business evolves and we continue to focus on commercial growth, broadening the industry expertise on our Board will help

      12/14/21 8:00:00 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Francis to the Board of Directors

      SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the appointment of Anshul Maheshwari as the company's Chief Financial Officer effective April 20, 2021, and the addition of Helen Loh and Laura Francis to its Board of Directors effective April 18, 2021. The appointment of Mr. Maheshwari completes the recently announced senior leadership transition which includes Laura Francis succeeding Jeff Dunn as Chief Executive Officer, and Tony Recupero becoming President, Commercial Operations. Jeff Dunn will remain with the compa

      4/19/21 7:00:49 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    SEC Filings

    See more
    • SEC Form 144 filed by SI-BONE Inc.

      144 - SI-BONE, Inc. (0001459839) (Subject)

      5/7/25 4:21:02 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by SI-BONE Inc.

      10-Q - SI-BONE, Inc. (0001459839) (Filer)

      5/6/25 4:05:51 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SI-BONE, Inc. (0001459839) (Filer)

      5/5/25 4:12:45 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on SI-BONE with a new price target

      Needham reiterated coverage of SI-BONE with a rating of Buy and set a new price target of $19.00 from $27.00 previously

      8/6/24 8:40:50 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Piper Sandler initiated coverage on SI-BONE with a new price target

      Piper Sandler initiated coverage of SI-BONE with a rating of Overweight and set a new price target of $25.00

      3/28/24 7:47:33 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Jefferies initiated coverage on SI-BONE with a new price target

      Jefferies initiated coverage of SI-BONE with a rating of Buy and set a new price target of $20.00

      10/12/22 9:04:16 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care